3.06 COVID-19 Vaccine Access, ADAURA, QOTW, & Journal Club with Fellow Dr. Karine Tawagi

Plenary Session

Vinay Prasad, MD MPH

Health, Medicine, Policy, Oncology, Science & Medicine

4.7 • 789 Ratings

🗓️ 7 August 2020

⏱️ 116 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

We start this week's episode by discussing access to investigational COVID-19 vaccines and recapping the problems with the ADAURA study. We transition from there to a Question of the Week with medical student Audrey Tran of Oregon Health & Science University. Finally, we introduce a new segment - Journal Club with a Fellow. In this inaugural segment we invite Dr. Karine Tawagi of the Oschner Clinic in Louisiana to the podcast to talk about IMbrave150. IMbrave150: doi.org/10.1056/NEJMoa1915745 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew

Transcript

Click on a timestamp to play from that location

0:00.0	Welcome. I'm Dr. Vinay Prasad. I'm a hematologist, oncologist, and I'm associate professor of medicine at the University of California, San Francisco. In my professional life, I see patients, I teach trainees, and I do research in health care policy. This is plenary session.
0:22.9	Plenary session is a podcast at the intersection of medicine, oncology, and health policy,
0:27.5	and you're listening to Season 3. On this week's episode. This week on Plenary Session, we have a lot
0:35.1	in store for you. It's going to be a great episode. I'm going to kick things off with a discussion of whether or not healthy people should be allowed access to investigational vaccines as phase three clinical trials are ongoing.
0:47.0	This is an idea that was first floated on the internet where all great original ideas are first floated.
0:52.5	Next, I have a recap on the Adora study. This is the study that
0:57.3	there have been many industry-sponsored debates about conceding that it is a great study. So I'm going to
1:02.5	take another crack at explaining the problems of Adora. Then, I'm joined via Zoom by Audrey Tran for
1:08.6	questions from a medical student. You won't want to miss this
1:11.1	far-reaching discussion. And last, we have the news segment, Journal Club with a fellow. I'm
1:17.0	joined by Dr. Corrine Tawaji, and she's going to take us through an article, a tazolizumab
1:21.3	and bevisimab in hepatocular carcinoma against seraphid. And you won't want to miss this
1:26.1	discussion. This is the
1:27.6	Embrave 150 discussion. So stay tuned. And a quick note. I promise that I would talk about a
1:34.1	precision oncology study, but this episode got too full. So I got to talk about that next week. So
1:39.2	stay tuned for that. If you like this podcast and want more content, follow me on Twitter at Viprasad MDMPH.
1:52.9	Check out the YouTube channel, Vinayprasad, MDMPH.
1:57.1	Patreon backers will get access to the slides for lectures I give on plenary session.
2:01.7	Want to hear from us?
2:02.9	Email us your question at plenary session podcast at gmail.com.
2:16.1	I really don't understand what's going on on Twitter and COVID-19.
2:20.6	The last few days have seen a flurry of interest around a terrible idea.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Vinay Prasad, MD MPH, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Vinay Prasad, MD MPH and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.